Ocugen - Stock Price History | OCGN

Historical daily share price chart and data for Ocugen since 2021 adjusted for splits. The latest closing stock price for Ocugen as of September 24, 2021 is 7.53.
  • The all-time high Ocugen stock closing price was 706.59 on January 05, 2015.
  • The Ocugen 52-week high stock price is 18.77, which is 149.3% above the current share price.
  • The Ocugen 52-week low stock price is 0.25, which is 96.7% below the current share price.
  • The average Ocugen stock price for the last 52 weeks is 5.62.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Ocugen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 0.4154 0.5107 2.6000 0.1962 1.8300 251.92%
2019 8.2822 7.3413 18.5629 0.2659 0.5200 -90.18%
2018 115.2026 123.9521 182.0359 5.2934 5.2934 -95.69%
2017 109.3071 99.4012 139.5210 88.6228 122.7545 22.75%
2016 143.4171 195.2096 240.1198 83.2335 100.0000 -52.29%
2015 407.7164 661.6766 706.5868 171.2575 209.5808 -68.18%
2014 658.3997 703.5928 703.5928 629.0419 658.6826 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.513B $0.043B
Ocugen Inc. is a clinical stage biopharmaceutical company. It is focused on discovering, developing and commercializing therapies which address rare and underserved eye diseases. The company's product pipeline consists of OCU400, OCU300, OCU100 and OCU200 which are in clinical stage. Ocugen Inc., formerly known as Histogenics Cp, is based in Malvern, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $134.727B 8.97
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.500B 21.17
Biohaven Pharmaceutical Holding (BHVN) United States $8.865B 0.00
Emergent Biosolutions (EBS) United States $2.891B 6.97
Arcus Biosciences (RCUS) United States $2.641B 0.00
Myovant Sciences (MYOV) United Kingdom $2.145B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.998B 0.00
Zymeworks (ZYME) Canada $1.380B 0.00
Ambrx Biopharma (AMAM) United States $0.521B 0.00
SQZ Biotechnologies (SQZ) United States $0.427B 0.00
Enzo Biochem (ENZ) United States $0.175B 51.71